Wenbo Xu

47.0k total citations · 1 hit paper
72 papers, 19.7k citations indexed

About

Wenbo Xu is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Wenbo Xu has authored 72 papers receiving a total of 19.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 35 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Wenbo Xu's work include Respiratory viral infections research (28 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral gastroenteritis research and epidemiology (11 papers). Wenbo Xu is often cited by papers focused on Respiratory viral infections research (28 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Viral gastroenteritis research and epidemiology (11 papers). Wenbo Xu collaborates with scholars based in China, United States and Taiwan. Wenbo Xu's co-authors include Xuejun Ma, Xiang Zhao, Baoying Huang, Wenjie Tan, Roujian Lu, Jingdong Song, George F. Gao, Dayan Wang, Guizhen Wu and Peihua Niu and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Wenbo Xu

69 papers receiving 19.2k citations

Hit Papers

A Novel Coronavirus from Patients with Pneumonia in China... 2020 2026 2022 2024 2020 5.0k 10.0k 15.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenbo Xu China 18 12.2k 3.3k 2.5k 2.0k 2.0k 72 19.7k
Jingdong Song China 22 12.6k 1.0× 3.4k 1.0× 2.5k 1.0× 2.0k 1.0× 2.0k 1.0× 99 20.5k
Na Zhu China 36 12.1k 1.0× 3.4k 1.0× 2.5k 1.0× 2.0k 1.0× 2.0k 1.0× 101 22.3k
Dingyu Zhang China 13 12.4k 1.0× 3.7k 1.1× 2.6k 1.0× 2.0k 1.0× 2.0k 1.0× 43 20.4k
Xuejun Ma China 29 13.1k 1.1× 3.4k 1.0× 2.5k 1.0× 2.1k 1.0× 2.0k 1.0× 138 21.4k
Xingwang Li China 18 12.2k 1.0× 3.4k 1.0× 2.5k 1.0× 2.1k 1.0× 2.0k 1.0× 54 20.4k
Faxian Zhan China 9 11.7k 1.0× 3.3k 1.0× 2.4k 1.0× 2.0k 1.0× 2.0k 1.0× 15 18.7k
Peihua Niu China 14 15.2k 1.2× 4.1k 1.2× 2.6k 1.1× 2.2k 1.1× 2.1k 1.1× 38 23.4k
Baoying Huang China 30 15.8k 1.3× 4.2k 1.3× 2.7k 1.1× 2.1k 1.1× 2.1k 1.1× 106 25.0k
Guizhen Wu China 21 15.2k 1.2× 3.9k 1.2× 3.1k 1.3× 2.5k 1.2× 2.2k 1.1× 75 24.3k
Roujian Lu China 23 15.9k 1.3× 4.3k 1.3× 3.1k 1.3× 2.2k 1.1× 2.2k 1.1× 53 25.1k

Countries citing papers authored by Wenbo Xu

Since Specialization
Citations

This map shows the geographic impact of Wenbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbo Xu more than expected).

Fields of papers citing papers by Wenbo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbo Xu. The network helps show where Wenbo Xu may publish in the future.

Co-authorship network of co-authors of Wenbo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenbo Xu. A scholar is included among the top collaborators of Wenbo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbo Xu. Wenbo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wenbo, et al.. (2024). Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer. Computers in Biology and Medicine. 180. 108989–108989. 6 indexed citations
2.
Zhang, Gang, et al.. (2024). Gene expression and immune infiltration analysis comparing lesioned and preserved subchondral bone in osteoarthritis. PeerJ. 12. e17417–e17417. 1 indexed citations
3.
Liu, Tingting, et al.. (2024). Real-time quantitative reverse transcription PCR assay for the detection of Nuomin virus – An emerging tick-borne virus. Journal of Virological Methods. 330. 115032–115032. 3 indexed citations
4.
5.
Xu, Wenbo, et al.. (2024). A coordinated trajectory tracking method with active utilization of drag for underwater vehicle manipulator systems. Ocean Engineering. 306. 118091–118091. 3 indexed citations
6.
Zhu, Zhen, Liwei Sun, Hui Zhang, et al.. (2023). Molecular Evolution of Human Parainfluenza Virus Type 2 Based on Hemagglutinin-Neuraminidase Gene. Microbiology Spectrum. 11(3). e0453722–e0453722. 4 indexed citations
7.
Zhu, Zhen, et al.. (2023). Circulation pattern and genetic variation of human respiratory syncytial virus in China during 2008–2021. Journal of Medical Virology. 95(3). e28611–e28611. 8 indexed citations
8.
Jiang, Haoran, Qi Qiu, Yan Zhang, et al.. (2023). The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China. Scientific Reports. 13(1). 15913–15913. 7 indexed citations
9.
Smith, Dallas J., et al.. (2022). COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022. China CDC Weekly. 4(14). 288–292. 17 indexed citations
10.
Zhou, Taicheng, Ao Li, Mei Yang, et al.. (2022). A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination. National Science Review. 9(7). nwac066–nwac066. 4 indexed citations
11.
Wang, Wenling, Li Zhao, Sheng Ye, et al.. (2022). The First Imported Case of Monkeypox in the Mainland of China — Chongqing Municipality, China, September 16, 2022. PubMed Central. 60 indexed citations
12.
Li, Kuibiao, Zhonghua Zheng, Xiang Zhao, et al.. (2022). An Imported Case and an Infected Close Contact of the Omicron Variant of SARS-CoV-2 — Guangdong Province, China, December 13, 2021. China CDC Weekly. 4(5). 96–97. 6 indexed citations
13.
Chen, Jida, et al.. (2022). A multiomic ferroptosis-associated prognostic signature incorporating epigenetic and transcriptional biomarkers for hepatocellular carcinoma. Translational Cancer Research. 11(7). 1889–1897. 4 indexed citations
14.
Zhang, Ruiqing, Shunxiang Qi, Jiandong Li, et al.. (2022). Field Evaluation of a Duplex RT-RAA Assay for Rapid Detection of SARS-CoV-2 - Hebei Province, China, January 2021.. PubMed. 4(23). 504–508. 4 indexed citations
15.
Chen, Fengjuan, Bosheng Li, Yang Song, et al.. (2021). A Case of New Variant COVID-19 First Emerging in South Africa Detected in Airplane Pilot — Guangdong Province, China, January 6, 2021. China CDC Weekly. 3(2). 28–29. 7 indexed citations
16.
Zhu, Na, Dingyu Zhang, Wen‐Ching Wang, et al.. (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 382(8). 727–733. 18577 indexed citations breakdown →
17.
Wang, Ji, Jun Zhao, Xiang Zhao, et al.. (2020). The First Case of Asymptomatic Infection of COVID-19 — Kashgar Prefecture, Xinjiang Uygur Autonomous Region, China, October, 2020. China CDC Weekly. 2(45). 882–883. 3 indexed citations
18.
Niu, Peihua, Xiang Zhao, Yang Pan, et al.. (2020). Reemergent Cases of COVID-19 — Xinfadi Wholesales Market, Beijing Municipality, China, June 11, 2020. China CDC Weekly. 2(27). 502–504. 26 indexed citations
19.
Zhao, Xiang, Lingling Mao, Jianqun Zhang, et al.. (2020). Reemergent Cases of COVID-19 — Dalian City, Liaoning Province, China, July 22, 2020. China CDC Weekly. 2(34). 658–660. 23 indexed citations
20.
Mao, Naiying, Yixin Ji, Zhengde Xie, et al.. (2012). Human Parainfluenza Virus-Associated Respiratory Tract Infection among Children and Genetic Analysis of HPIV-3 Strains in Beijing, China. PLoS ONE. 7(8). e43893–e43893. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026